[Microbiological point of care tests]

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Early anti-infective therapy is critical for reducing mortality in severe infections.
• Current gold standard culture methods take 24-48 hours, leading to empirical therapy with unknown effectiveness.
• Pathogen-specific point-of-care tests are inadequate for infections with diverse potential pathogens.

Purpose of the Study:

• To evaluate the potential of novel molecular diagnostic systems for rapid pathogen identification in severe infections.
• To assess the impact of accelerated diagnostics on empirical antimicrobial therapy duration.
• To identify limitations and future directions for molecular diagnostic technologies in clinical microbiology.

Main Methods:

• Utilized a novel, culture-independent polymerase chain reaction (PCR) system.
• The system identifies the 25 most frequent sepsis pathogens in parallel.
• Analysis time for the PCR system is less than 6 hours.

Main Results:

• The new PCR system significantly reduces pathogen identification time compared to traditional culture methods.
• This acceleration may shorten the window of potentially ineffective empirical antimicrobial therapy.
• Current limitations include the system's extensive nature, unsuitability for point-of-care use, and a need for miniaturization and expanded pathogen/resistance gene detection.

Conclusions:

• Molecular PCR techniques show promise for significantly impacting future microbiological diagnostics.
• Further development is needed for miniaturization, automation, and broader pathogen/resistance gene detection for point-of-care application.
• Accelerated diagnostics through PCR can improve patient outcomes in severe infections like sepsis.